Literature DB >> 4835128

Measurement of serum LH, FSH, estradiol and progesterone in disorders of the human menstrual cycle: the inadequate luteal phase.

B M Sherman, S G Korenman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4835128     DOI: 10.1210/jcem-39-1-145

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  20 in total

1.  Risk of complex and atypical endometrial hyperplasia in relation to anthropometric measures and reproductive history.

Authors:  Meira Epplein; Susan D Reed; Lynda F Voigt; Katherine M Newton; Victoria L Holt; Noel S Weiss
Journal:  Am J Epidemiol       Date:  2008-08-05       Impact factor: 4.897

2.  Changes in immune cell distribution and their cytokine/chemokine production during regression of the rhesus macaque corpus luteum.

Authors:  Cecily V Bishop; Fuhua Xu; Rosemary Steinbach; Ellie Ficco; Jeffrey Hyzer; Steven Blue; Richard L Stouffer; Jon D Hennebold
Journal:  Biol Reprod       Date:  2017-06-01       Impact factor: 4.285

3.  Height, body mass index (BMI), BMI change, and the risk of estrogen receptor-positive, HER2-positive, and triple-negative breast cancer among women ages 20 to 44 years.

Authors:  Masaaki Kawai; Kathleen E Malone; Mei-Tzu C Tang; Christopher I Li
Journal:  Cancer       Date:  2014-02-05       Impact factor: 6.860

4.  Characterization of luteal function by measuring the cumulative concentration of serum progesterone and urine pregnanediol-3 alpha-monoglucuronide.

Authors:  G Aprò; G Falkay; M Sas
Journal:  J Endocrinol Invest       Date:  1983-06       Impact factor: 4.256

5.  Corpus luteum dysfunction and the epidemiology of breast cancer: a reconsideration.

Authors:  B M Sherman; R B Wallace; S G Korenman
Journal:  Breast Cancer Res Treat       Date:  1981       Impact factor: 4.872

6.  Estradiol Priming Improves Gonadotrope Sensitivity and Pro-Inflammatory Cytokines in Obese Women.

Authors:  Zain A Al-Safi; Huayu Liu; Nichole E Carlson; Justin Chosich; Jennifer Lesh; Celeste Robledo; Andrew P Bradford; Nancy A Gee; Tzu Phang; Nanette Santoro; Wendy Kohrt; Alex J Polotsky
Journal:  J Clin Endocrinol Metab       Date:  2015-10-01       Impact factor: 5.958

Review 7.  Hormonal therapy for epilepsy.

Authors:  Scott J Stevens; Cynthia L Harden
Journal:  Curr Neurol Neurosci Rep       Date:  2011-08       Impact factor: 5.081

8.  Adult body size, hormone receptor status, and premenopausal breast cancer risk in a multiethnic population: the San Francisco Bay Area breast cancer study.

Authors:  Esther M John; Meera Sangaramoorthy; Amanda I Phipps; Jocelyn Koo; Pamela L Horn-Ross
Journal:  Am J Epidemiol       Date:  2010-11-17       Impact factor: 4.897

9.  Factors related to declining luteal function in women during the menopausal transition.

Authors:  N Santoro; S L Crawford; W L Lasley; J L Luborsky; K A Matthews; D McConnell; J F Randolph; E B Gold; G A Greendale; S G Korenman; L Powell; M F Sowers; G Weiss
Journal:  J Clin Endocrinol Metab       Date:  2008-02-19       Impact factor: 5.958

10.  Rapid Mouse Follicle Stimulating Hormone Quantification and Estrus Cycle Analysis Using an Automated Microfluidic Chemiluminescent ELISA System.

Authors:  Xiaotian Tan; Anu David; James Day; Haoyue Tang; Emily Rose Dixon; Hongbo Zhu; Yu-Cheng Chen; Maung Kyaw Khaing Oo; Ariella Shikanov; Xudong Fan
Journal:  ACS Sens       Date:  2018-10-29       Impact factor: 7.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.